• Home
  • About Us
    • Meet Our Team
    • Vision, Mission and Core Values
    • Trusted Partners
    • Giving Back
    • In the News
    • Careers
  • For Patients
    • Study Opportunities
    • Clinical Trial Opportunities
    • Sign Up to Participate
    • Types of Research
    • Find Us in the Community
    • Frequently Asked Questions
    • How We Use Your Information
    • Newsletters
  • For Advocacy Groups
  • For Researchers
    • Patient/Caregiver Panels
    • Pricing
    • Proposal Requests
    • Frequently Asked Questions
    • Industry Conferences
    • Diseases
      • Hemophilia
      • Multiple Sclerosis
      • Breast Cancer
      • Diabetes
      • Multiple Myeloma
      • Epilepsy
      • Non-Small Cell Lung Cancer
      • HIV
  • Blog
    • Patient Blog
    • Business Blog
  • Sign In
  • Case Studies
    • The Long and Winding Road to Care
    • Health Literacy Initiative’s PSA
    • Patient Perspectives on Clinical Trial Participation
    • Patient Journeys and Insights for Oncology and Rare Diseases
    • Market Access: A Patient Perspective
    • The Impact of Rare Diseases on Patients and Caregivers
    • The Role of Patient Advocacy Groups
    • Zebras Do Exist: The Diagnostic Odyssey of Rare Disease Patients
    • Patient Insights on Telehealth: A Case Study
    • Hearing is Believing: Reducing Barriers to Amplify the Patient Voice

Rare Patient Voice

Helping Patients with Rare Diseases Voice Their Opinions

  • Home
  • About Us
    • Meet Our Team
    • Vision, Mission and Core Values
    • Trusted Partners
    • Giving Back
    • In the News
    • Careers
  • For Patients
    • Study Opportunities
    • Clinical Trial Opportunities
    • Sign Up to Participate
    • Types of Research
    • Find Us in the Community
    • Frequently Asked Questions
    • How We Use Your Information
    • Newsletters
  • For Advocacy Groups
  • For Researchers
    • Patient/Caregiver Panels
    • Pricing
    • Proposal Requests
    • Frequently Asked Questions
    • Industry Conferences
    • Diseases
      • Hemophilia
      • Multiple Sclerosis
      • Breast Cancer
      • Diabetes
      • Multiple Myeloma
      • Epilepsy
      • Non-Small Cell Lung Cancer
      • HIV
  • Blog
    • Patient Blog
    • Business Blog
  • Sign In
  • Case Studies
    • The Long and Winding Road to Care
    • Health Literacy Initiative’s PSA
    • Patient Perspectives on Clinical Trial Participation
    • Patient Journeys and Insights for Oncology and Rare Diseases
    • Market Access: A Patient Perspective
    • The Impact of Rare Diseases on Patients and Caregivers
    • The Role of Patient Advocacy Groups
    • Zebras Do Exist: The Diagnostic Odyssey of Rare Disease Patients
    • Patient Insights on Telehealth: A Case Study
    • Hearing is Believing: Reducing Barriers to Amplify the Patient Voice

Helping patients and caregivers share their voices

Wes Michael in PharmaVOICE on How Successful Clinical Trial Recruitment Depends on Listening to Patients

March 24, 2022 Laura Mullen

Rare Patient Voice President Wes Michael was interviewed recently by PharmaVOICE’s Kim Ribbink in the article, “Rare Patient Voice’s President is Striving to Create a Five-star Experience for Patients,” which was published on March 23, 2022. When asked why the patient voice is so important in the development and patient recruitment process, Wes provided a thought-provoking answer:

“Without hearing from patients, researchers can make wrong decisions. I remember being at a pulmonary fibrosis conference with patients, physicians and researchers. The researchers were developing treatments to save patients’ lives. The patients were grateful, but they said the cough was making their quality of life suffer. The researchers said the cough wasn’t what was killing them, but the patients pushed back and said they didn’t want to live with that cough. Ultimately, the researchers heard the voice of the patient and learned how important that facet of their quality of life was to them.

Another example is treatment for erythropoietic protoporphyria (EPP), a condition that causes patients severe pain on exposure to sunlight and some artificial light. One patient, who is also a researcher, noted that a treatment under investigation lengthened the time before the burning sensation began to happen. While regulators were saying this time duration wasn’t enough to help anybody, the feedback from patients led regulators to look at the data again and the product was approved.

The industry is learning to listen more and regulatory bodies are also asking for the patient perspective. It’s no longer enough just to consider expert opinion; increasingly it’s become important to engage patients and advocacy groups.”

The PharmaVOICE is available in its entirety here.

Filed Under: Business Tagged With: EPP, erythropoietic protoporphyria, PharmaVOICE, Wes Michael

Latest Blog Posts

  • Real & Rare with Sarah: The Stages of Life with a Rare Disease
  • Weekly Warrior: Meet Rachel
  • The Rare Disorder Podcast interviews RPV’s Wes Michael
  • Weekly Warrior: Meet Sam
  • Real & Rare with Sarah: Make Time for You

Check Out Our YouTube Channel!

https://youtu.be/cfjkqh5Ykp0

Read Our Newsletter

Read our Newsletter
What’s New at Rare Patient Voice?

Rare Patient Voice

711 Hampton Lane
Towson, Maryland 21286
ContactUs@RarePatientVoice.com
(443) 986-1949


Visit our international site, rarepatientvoice.global


Careers


For Patients

  • Learn about us
  • Vision, Mission and Core Values
  • Sign up to participate
  • Find us in the community
  • Read our blog for patients
  • Privacy Policy

For Related Groups

  • Are you an advocacy group for a rare disease?
  • Are you a researcher?
  • Read our blog for businesses

   Instagram

     

Rare Patient Voice, LLC, Market Research, Towson, MD

©2022. Rare Patient Voice. All Rights
Reserved. Privacy Policy. Disclaimers. Sitemap

©2022 . All Rights Reserved.

Copyright © 2022 · Genesis Framework · WordPress · Log in

Search Our Website

We use cookies to ensure the best experience with Rare Patient Voice. By clicking “Accept”, you agree to our privacy policy.
Privacy Policy   |    Cookies    |    Accept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT